Skip to content
lifestyle.forkstofeet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Genmab A/S
Genmab Announces Financial Results for the First Half of 2026
August 6, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
July 15, 2026
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
June 29, 2026
Major Shareholder Announcement
June 15, 2026
Major Shareholder Announcement
April 14, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
April 14, 2026
Major Shareholder Announcement
April 1, 2026
Major Shareholder Announcement
March 30, 2026
Genmab Publishes 2025 Annual Report
February 17, 2026